Dec 19 @ 1:00 pm - 2:00 pm
19:00 CET | 18:00 GMT | 1:00 p.m. ET | 12:00 p.m. CT | 11:00 a.m. MT | 10:00 a.m. PT
Annual Drug Development Update
Presented by Nicholas Johnson, MD, Virginia Commonwealth University.
This is our annual update on therapy development for FSHD. We’ll hear the latest on Fulcrum, Avidity, and Roche’s clinical trials, as well as updates on FSHD programs from Arrowhead, Dyne, and Epic Bio. What strategies are being considered? How are different candidate drugs progressing through the process of reaching the clinic? What’s coming in 2026? Nick Johnson, MD, director of the FSHD research center at Virginia Commonwealth University, will present the latest news and answer your questions.
